Non-alcoholic fatty liver disease is a risk factor for occurrence of hepatocellular carcinoma after sustained virologic response in chronic hepatitis C patients: A prospective four-years follow-up study.
Metabol Open
; 10: 100090, 2021 Jun.
Article
en En
| MEDLINE
| ID: mdl-33889834
AFP, alpha-fetoprotein; ALT, alanine aminotransferase; ANGPTL, angiopoietin-like proteins; AST, aspartate aminotransferase; ASV, asunaprevir; BCLC, Barcelona-Clinic Liver Cancer Group; BMI, body mass index; CHC, chronic hepatitis C; CI, confidence intervals (CI); Chronic hepatitis C; DAAs, direct-acting antiviral agents; DCV, daclatasvir; FGF, fibroblast growth factor; HCC; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; HR, Hazard Ratio; IFN, interferon; LDV, ledipasvir; LSM, liver stiffness measurement; NAFLD; PLT, platelet count; PR, Peg-IFN-α with RBV; Peg-IFN, Pegylated interferon; RBV, ribavirin; SMV, simeprevir; SOF, sofosbuvir; SVR, sustained virologic response; Sustained virologic response; TBIL, total bilirubin; TNF, tumor necrosis factor; ULN, upper limit of normal
Texto completo:
1
Bases de datos:
MEDLINE
Tipo de estudio:
Etiology_studies
/
Observational_studies
/
Prognostic_studies
/
Risk_factors_studies
Idioma:
En
Revista:
Metabol Open
Año:
2021
Tipo del documento:
Article
País de afiliación:
China